Brind.

Steve Rudderham held executive roles at Novartis, Syngenta, AkzoNobel, and Genpact before joining Aokah's Advisory Board.

1 report, 1 independent Updated Sep 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Syngenta

How it developed

Newest first. Tap a step to see who reported it.

Sep 8Alpa Inamdar was appointed to advise on the strategic direction of Aokah.Sub-event
Sep 3Steve Rudderham's executive career history and new role at Aokah.1 source
- PR Newswire

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
Syngenta
Swiss agricultural technology company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 3PR NewswireAokah Appoints Robert Weltevreden to Board of Directors and Steve Rudderham as Chairperson of Advisory Board NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Aokah, the Execution Intelligence platform orchest